CD8A and type 2 diabetes mellitus: We have also highlighted a hitherto novel role of the CD8 checkpoint blockade in promoting de novo functional revascularization by stimulating EC proliferation and function; and by unleashing CD8+ T-cells from the effector/effector memory specification in T2D mice.